Savara (SVRA) Capital Leases (2015 - 2018)

Savara's (SVRA) quarterly Capital Leases came in at $297000.0 in Q1 2018, up 2021.43% year-on-year from $14000.0 in Q1 2017, and little changed on a QoQ basis from $297000.0 in Q4 2017.

Savara (SVRA) Capital Leases (2015 - 2018) Analysis & Trends

Savara (SVRA) has 4 years of Capital Leases data on file, last reported at $297000.0 in Q1 2018.

  • On a quarterly basis, Capital Leases rose 2021.43% year-over-year to $297000.0 in Q1 2018; TTM through Mar 2018 was $297000.0, a 2021.43% increase from a year earlier, with the FY2017 full-year figure at $297000.0, down 48.7% from the prior year.
  • Capital Leases for Q1 2018 stood at $297000.0, roughly flat from $297000.0 in the prior quarter.
  • Over the last five years, Capital Leases for SVRA reached as high as $579000.0 in Q4 2016 and fell as low as $14000.0 in Q1 2017.
  • Historically, Capital Leases has averaged $172181.8 across 4 years, with a median of $25000.0 in 2015.
  • Across the five-year window, Capital Leases jumped 2216.0% in 2016 and sank 48.7% in 2017, its largest moves.
  • Year by year, Capital Leases stood at $25000.0 in 2015, then soared by 2216.0% to $579000.0 in 2016, then sank by 48.7% to $297000.0 in 2017, then changed by 0.0% to $297000.0 in 2018.
  • Per Business Quant data, the three most recent Capital Leases figures were $297000.0 in Q1 2018, $297000.0 in Q4 2017, and $297000.0 in Q3 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Savara 1.24 Bn 1.24 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2018 297,000.00
Dec 31, 2017 297,000.00
Sep 30, 2017 297,000.00
Jun 30, 2017 297,000.00
Mar 31, 2017 14,000.00
Dec 31, 2016 579,000.00
Sep 30, 2016 19,000.00
Jun 30, 2016 21,000.00
Mar 31, 2016 24,000.00
Dec 31, 2015 25,000.00
Sep 30, 2015 24,000.00